Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
edetate calcium disodium
- Development stage
- Approved
- Lead developer
- Rising Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Intravenous, Intramuscular
01
Overview
Edetate calcium disodium is a small molecule chelating agent primarily indicated for the reduction of blood lead levels and the treatment of lead poisoning. In clinical research led by **Chang Gung Memorial Hospital**, it has been investigated for its potential to slow the progression of **chronic renal insufficiency** in non-diabetic patients who possess a high-normal body lead burden. The drug functions by binding to divalent and trivalent heavy metals—most notably lead—to form stable, water-soluble complexes that are subsequently eliminated from the body via urinary excretion. The therapeutic rationale in renal disease is based on the hypothesis that reducing cumulative lead exposure can mitigate chronic lead-induced nephrotoxicity and preserve glomerular filtration rates over time.
- Brand names
- Calcium Disodium Versenate
- Other names
- calcium disodium EDTACaNa2EDTACaNa-2EDTACaNa 2EDTAedetate calciumcalcium EDTA
02
Targets
CD2 (T-cell Surface Antigen CD2)PB2 (Influenza PB2)Zn2+ (Zinc ion)Fe3+ (Ferric iron)
Beyond the preview
Go deeper on edetate calcium disodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on edetate calcium disodium.